Vietnam Pharmaceuticals & Healthcare Report Q2 2013 - New Report Available
Vietnam represents a high-reward, high-risk market for pharmaceutical firms. We expect the country to be one of the next key emerging markets as growth in countries such as China is expected to slow down as it transits from a developing to a developed country. The current lack of access to healthcare meant unmet medical needs, which pharmaceutical firms and healthcare providers can leverage on for future growth. However, a key downside risk that will stunt growth is corruption.
View full press release